Author Search Results

1

Clinical Utility of Fedratinib in Myelofibrosis

by Waksal JA, Tremblay D, Mascarenhas J
Published 2021-08-01

Get full text

Article
2

Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis

by Al-Fayoumi S, Hashiguchi T, Shirakata Y, Mascarenhas J, Singer JW
Published 2018-05-01

Get full text

Article
3

MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia

by Alves da Silva, P.H, Ferrari de Andrade, L., Kotini, A.G, Mascarenhas, J., Papapetrou, E.P, Song, X., Wucherpfennig, K.W, Xing, S.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
4

Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes

by Verstovsek S, Gotlib J, Gupta V, Atallah E, Mascarenhas J, Quintas-Cardama A, Sun W, Sarlis NJ, Sandor V, Levy RS, Kantarjian HM, Mesa RA
Published 2013-12-01

Get full text

Article
5

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase

by Davis, A., Farnoud, N., Hoffman, R., Hu, C.S, Iancu-Rubin, C., Kremyanskaya, M., Lu, M., Mascarenhas, J., McGovern, E., Najfeld, V., Patel, M., Petersen, B., Rampal, R.K, Rossi, M.R, Tripodi, J., Wang, X., Weinberg, R.S
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
6

ESTUDO MOLECULAR DE VÍRUS ASSOCIADOS À DIARREIA EM CRIANÇAS QUILOMBOLAS DO NORTE DO ESTADO DO ESPÍRITO SANTO.

by VICENTINI, F.
Published 2016
Other Authors: “...MASCARENHAS, J. D. A. P....”

Get full text

Others